Labtronics Inc. announces the introduction of a new LimsLinkCDS interface, which provides a direct and transparent connection between the Agilent ChemStation Plus Chromatography Data Systems and any LIMS. New menu items allow access to the LIMS from within the CDS application.
SQL*LIMS version 5.0 includes an enhanced user interface delivered via a Web services application that provides an enterprise-accessible tool for pharmaceutical manufacturing groups and global organizations.
Bioinformatics Solutions Inc. has announced that a Perl API is now available to the company's PROSPECT Pro user community. Cavanagh and Hart, from the Bioinformatics Department at Genentech Inc.
Geospiza hasannounced the release of the Finch® Trace Viewer, FinchTV, a freely available software utility for viewing DNA sequencing chromatogram files.
Use of 1- or 2-D gel electrophoresis followed by enzymatic digestion and mass spectrometry (MS) analysis is currently the most predominant workflow for protein identification.
by Elizabeth Tolchin As part of the Genomics:GTL (formerly Genomes to Life) project, funded by the US Department of Energy, researchers from Lawrence Berkeley National Laboratory, Berkeley, Calif., are using phenotype microarrays to rapidly deduce the stress-response pathways in metal- and radionuclide-reducing bacteria.
by Elizabeth Tolchin A group of chemists at Northwestern University, Chicago, claim they developed a diagnostic method that is much faster, easier to use, more accurate, and less expensive than polymerase chain reaction (PCR).
Eleventh Annual Cell-Based Assay Development for HTS May 17-18, 2004, Philadelphia, Pennsylvania
Parker XRS Systems, pre-engineered cartesian robots, offer off the shelf multi-axis solutions for liquid handling, microarrays and liquid dispensing. Over 120 standard XY and XYZ systems are available with payloads up to 25 kg and work areas to 1 × 1 meter.
by Elizabeth Tolchin In a final resolution to a long-labored issue, the US Food and Drug Administration (FDA) issued a mandate this week requiring all pancreatic extract manufacturers to have their products approved by the FDA within the next four years in order to remain on the market.
by Elizabeth Tolchin According to participants and conference organizers, much of the buzz at the 13th Annual Partnerships with CROs & Other Outsourcing Providers conference, taking place this week in Orlando, Fla., was on a new strategic partnership model. But some say it's an idea that is not materializing.
Intrinsic and acquired drug resistance to various classes of chemically diverse chemotherapy agents (referred to as "MultiDrug Resistance", MDR) represents the major obstacle in modern cancer chemotherapy.
by Robert Ford An assay technology developed by a Hungarian company should enable researchers at MDS Pharma Services, Montreal, Canada, to better ensure that patients using multiple medications are receiving the full dosage of their medication rather than excreting them.
by Elizabeth Tolchin With antiquated legislation going back to the Wild West days, Arizona is one of the only remaining states to not allow its universities to take equity positions in companies stemming from scientific discoveries by faculty. That may change in November when a new bill concerning technology transfer will be posted with the state general election.
by Elizabeth Tolchin As part of a phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute, Bethesda, Md., Aastrom Biosciences Inc. will conduct a $124,000, eight-month study to demonstrate the feasibility and advantages of their technology to culture T lymphocytes or T cells for treatment against malignant melanoma.